Loading content...
Loading comments...
CARVEDILOL
Wed Jun 04 2025
Reason for Recall
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
Manufacturers
| Drug | Manufacturer |
|---|---|
| CARVEDILOL | Glenmark Pharmaceuticals Inc., USA |
Number of affected units
84,048 bottles
Distribution pattern
U.S. Nationwide
UPCs
Info not provided.
Package NDCs
| NDC |
|---|
| 68462-162-60 |
| 68462-162-01 |
| 68462-162-18 |
| 68462-162-05 |
| 68462-162-10 |
| 68462-163-60 |
| 68462-163-01 |
| 68462-163-18 |
| 68462-163-05 |
| 68462-163-10 |
| 68462-164-60 |
| 68462-164-01 |
| 68462-164-18 |
| 68462-164-05 |
| 68462-164-10 |
| 68462-165-60 |
| 68462-165-01 |
| 68462-165-18 |
| 68462-165-05 |
| 68462-165-10 |
Comments (-)
Must be signed in to post a comment.
No comments.